Loading...
XSTOACARIX
Market cap26mUSD
Dec 23, Last price  
0.28SEK
1D
-2.48%
1Q
-7.25%
Jan 2017
-98.24%
IPO
-97.49%
Name

Acarix AB

Chart & Performance

D1W1MN
XSTO:ACARIX chart
P/E
—
P/S
46.87
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
72.66%
Rev. gr., 5y
43.55%
Revenues
6m
+7.20%
000638,0001,024,0001,857,0002,170,0003,760,0005,822,0006,241,000
Net income
-78m
L+0.44%
-19,209,000-12,393,000-48,240,000-29,776,000-42,271,000-46,459,000-41,548,000-51,802,000-77,495,000-77,839,000
CFO
-81m
L+8.68%
-20,871,000-8,631,000-9,056,000-40,539,000-38,609,000-44,533,000-36,686,000-48,007,000-74,869,000-81,366,000
Earnings
Feb 13, 2025

Profile

Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.
URL
https://acarix.com/
IPO date
Dec 19, 2016
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
6,241
7.20%
5,822
54.84%
3,760
73.27%
Cost of revenue
83,794
82,297
55,456
Unusual Expense (Income)
NOPBT
(77,553)
(76,475)
(51,696)
NOPBT Margin
Operating Taxes
510
71
Tax Rate
NOPAT
(77,553)
(76,985)
(51,767)
Net income
(77,839)
0.44%
(77,495)
49.60%
(51,802)
24.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
106,443
69,335
580
BB yield
-118.03%
-87.16%
-0.39%
Debt
Debt current
251
284
Long-term debt
251
762
Deferred revenue
Other long-term liabilities
1,000
1,000
1,000
Net debt
(35,149)
(6,640)
(14,764)
Cash flow
Cash from operating activities
(81,366)
(74,869)
(48,007)
CAPEX
(151)
(43)
Cash from investing activities
(151)
(43)
Cash from financing activities
106,229
69,030
(164)
FCF
(56,083)
(33,488)
(119,302)
Balance
Cash
35,149
6,621
15,810
Long term investments
521
Excess cash
34,837
6,851
15,622
Stockholders' equity
(540,268)
(467,734)
(394,418)
Invested Capital
592,154
519,811
495,486
ROIC
ROCE
EV
Common stock shares outstanding
475,130
279,107
170,514
Price
0.19
-33.40%
0.29
-67.32%
0.87
-26.41%
Market cap
90,180
13.37%
79,546
-46.50%
148,688
17.79%
EV
55,031
72,906
133,924
EBITDA
(74,465)
(73,438)
(48,318)
EV/EBITDA
Interest
132
163
71
Interest/NOPBT